Tango Therapeutics (TNGX) FCF Margin (2020 - 2025)
Tango Therapeutics (TNGX) posted quarterly FCF Margin of 57.36% for Q3 2025, up 22558.0% year-over-year from N/an in Q3 2024, and up 95.04% quarter-over-quarter from 1156.05% in Q2 2025.
Tango Therapeutics (TNGX) FCF Margin (2020 - 2025) Analysis & Trends
Tango Therapeutics' FCF Margin history runs 6 years deep, the most recent figure standing at 57.36% for Q3 2025.
- In Q3 2025, FCF Margin rose 22558.0% year-over-year to 57.36%; the TTM figure through Mar 2026 stood at 248.78% (up 8344.0% YoY), while the FY2025 annual figure was 223.11%, up 9127.0% from the prior year.
- FCF Margin for Q3 2025 stood at 57.36%, up from 1156.05% in the prior quarter.
- The five-year high for FCF Margin was 40.43% in Q2 2021, with the low at 1156.05% in Q2 2025.
- The 5-year median for FCF Margin is 379.62% (2022), against an average of 432.4%.
- The sharpest annual moves came in 2023 and 2025: FCF Margin jumped 36549 bps in 2023, then tumbled 103451 bps in 2025.
- Tango Therapeutics' FCF Margin stood at 291.1% in 2021, then slumped by 57 bps to 457.14% in 2022, then slipped by 6 bps to 482.51% in 2023, then slumped by 88 bps to 909.28% in 2024, then surged by 94 bps to 57.36% in 2025.
- Business Quant data shows TNGX's FCF Margin at 57.36% in Q3 2025, 1156.05% in Q2 2025, and 774.26% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 25.68% |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -77,594.17% |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 70.82% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 22.62% |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -22.35% |
| 10 | Tango Therapeutics | 4.32 Bn | 3.30 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -57.36% |
| Jun 30, 2025 | -1,156.05% |
| Mar 31, 2025 | -774.26% |
| Dec 31, 2024 | -909.28% |
| Sep 30, 2024 | -282.94% |
| Jun 30, 2024 | -121.54% |
| Mar 31, 2024 | -584.48% |
| Dec 31, 2023 | -482.51% |
| Sep 30, 2023 | -290.26% |
| Jun 30, 2023 | -172.19% |
| Mar 31, 2023 | -616.15% |
| Dec 31, 2022 | -457.14% |
| Sep 30, 2022 | -379.62% |
| Jun 30, 2022 | -537.69% |
| Mar 31, 2022 | -523.88% |
| Dec 31, 2021 | -291.10% |
| Sep 30, 2021 | -323.03% |
| Jun 30, 2021 | -40.43% |
| Mar 31, 2021 | -215.75% |
| Dec 31, 2020 | -23.12% |